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Abstract
Background: Human neutrophils are central players in innate immunity, a major component of inflammatory responses,
and a leading model for cell motility and chemotaxis. However, primary neutrophils are short-lived, limiting their
experimental usefulness in the laboratory. Thus, human myeloid cell lines have been characterized for their
ability to undergo neutrophil-like differentiation in vitro. The HL-60 cell line and its PLB-985 sub-line are commonly
used to model human neutrophil behavior, but how closely gene expression in differentiated cells resembles that of
primary neutrophils has remained unclear.
Results: In this study, we compared the effectiveness of differentiation protocols and used RNA sequencing (RNA-seq)
to compare the transcriptomes of HL-60 and PLB-985 cells with published data for human and mouse primary
neutrophils. Among commonly used differentiation protocols for neutrophil-like cell lines, addition of dimethyl
sulfoxide (DMSO) gave the best combination of cell viability and expression of markers for differentiation.
However, combining DMSO with the serum-free-supplement Nutridoma resulted in increased chemotactic
response, phagocytic activity, oxidative burst and cell surface expression of the neutrophil markers FPR1 and
CD11b without a cost in viability. RNA-seq analysis of HL-60 and PLB-985 cells before and after differentiation
showed that differentiation broadly increases the similarity in gene expression between the cell lines and primary
neutrophils. Furthermore, the gene expression pattern of the differentiated cell lines correlated slightly better with that
of human neutrophils than the mouse neutrophil pattern did. Finally, we created a publicly available gene expression
database that is searchable by gene name and protein domain content, where users can compare gene expression in
HL-60, PLB-985 and primary human and mouse neutrophils.
Conclusions: Our study verifies that a DMSO-based differentiation protocol for HL-60 and PLB-985 cell lines gives
superior differentiation and cell viability relative to other common protocols, and indicates that addition of
Nutridoma may be preferable for studies of chemotaxis, phagocytosis, or oxidative burst. Our neutrophil gene
expression database will be a valuable tool to identify similarities and differences in gene expression between
the cell lines and primary neutrophils, to compare expression levels for genes of interest, and to improve the
design of tools for genetic perturbations.
Keywords: Neutrophil-like cell line, Differentiation protocol, Chemotaxis, RNA-seq, Database, Neutrophil
Background
Neutrophils are the most abundant immune cell popula-
tion circulating in the human bloodstream, representing
50–70% of all leukocytes. They are generated from mye-
loid precursors in the bone marrow, where they undergo
several stages of maturation, namely myeloblast, promye-
locyte, myelocyte, metamyelocyte, band cell and finally
polymorphonuclear neutrophil [1]. From the bloodstream,
neutrophils are rapidly recruited to sites of inflammation,
migrating up gradients of chemical cues in a process
called chemotaxis. Neutrophils are among the world’s
most accurate chemotaxing cells, and serve as a leading
model for eukaryotic chemotaxis [2]. Once at the inflam-
mation site, neutrophils respond to the chemoattractant
signals with cytotoxic and inflammatory responses, includ-
ing secretion of granules (degranulation), ingestion of mi-
crobes and other particles (phagocytosis), and generation
of neutrophil extracellular traps that catch and kill extra-
cellular microbes. Neutrophil responses require a fine
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balance: underactivity leaves the body vulnerable to inva-
sion, while over-activity is implicated in inflammatory and
autoimmune diseases, and cancer progression [1, 3].
Despite much interest in understanding the molecular
mechanisms underlying human neutrophil behaviors,
their use in experimental research is limited by their
very short life-span. They begin to undergo apoptosis
within 6 to 12 h after isolation [1], making techniques
such as genetic perturbation impractical. To address this
issue, human myeloid cell lines have been established and
characterized for their ability to undergo neutrophil-like
differentiation in vitro [4, 5]. The HL-60 cell line, estab-
lished in 1977 from an acute myeloid leukemia patient, is
one of the most commonly used [6]. HL-60 cells are at the
myeloblast stage of development but can be induced to
differentiate terminally in vitro to either a neutrophil-like
or a monocyte-like state. Neutrophilic differentiation
causes a decrease in cell size, increased nuclear pyknosis
and segmentation, and alterations in gene and protein ex-
pression. This in vitro differentiation makes HL-60 cells a
good model to study neutrophil behaviors such as chemo-
taxis and phagocytosis [7–9], as well as the myeloid differ-
entiation process itself [10]. A second commonly used cell
line, PLB-985, was originally reported as being established
in 1985 from a different patient [11]. However, further
characterization determined that PLB-985 is actually a
sub-line of HL-60 [12]. PLB-985 cells have similar, but
slightly different, properties from those of HL-60 cells,
and they are used to study processes including neutrophil
ROS production [13] and chemotaxis [14–16]. These cell
lines serve as primary model systems, but even so, they do
not fully recapitulate all neutrophil behaviors [5, 17]. Im-
portant outstanding questions include to what degree the
in vitro differentiated cells recapitulate neutrophil gene
expression, and what differences in gene expression exist
that may affect particular neutrophil behaviors.
Additionally, it is still not clear which of the commonly
used reagents and protocols best induces differentiation of
HL-60 and PLB-985 cells into a neutrophil-like state.
Dimethyl sulfoxide (DMSO), all-trans retinoic acid
(ATRA), and dibutyryl cyclic adenosine monophosphate
(dbcAMP) are all commonly used to induce differentiation
[5, 11, 18]. While ATRA and dbcAMP are thought to
regulate transcription through cognate retinoic acid recep-
tors and cAMP signaling, respectively, the mechanism for
DMSO is much less clear. DMSO may act by altering
membrane permeability and microviscosity, by affecting
synthesis of nucleic acid and proteins, or by inducing
changes in chromatin [19–21]. Additional reagents have
also been reported to improve the efficiency of differ-
entiation. In particular, addition of caffeic acid (CA)
[22], replacement of serum with the supplement
Nutridoma [23], and stimulation with the cytokine
granulocyte colony-stimulating factor (G-CSF) [24] have
each been used to promote neutrophilic differentiation in
some contexts.
We wanted to address the above outstanding questions
by first determining an optimal protocol for efficient neu-
trophilic differentiation, and then characterizing gene ex-
pression in differentiated cells for systematic comparison
with primary neutrophils. Our study indicates that
DMSO-based differentiation achieves the best balance of
neutrophil marker expression with high cell viability and
function, and that the use of Nutridoma can further in-
crease cell surface expression of at least some neutrophil
markers, including the Formyl Peptide Receptor 1 (FPR1).
Our RNA sequencing (RNA-seq) analysis of HL-60 and
PLB-985 transcriptomes confirmed that differentiation
markedly increases the correlation in gene expression be-
tween the cell lines and human neutrophils, slightly ex-
ceeding the correlation between mouse and human
neutrophil gene expression. Finally, we organized our
data, together with previously published data, in a public
neutrophil gene expression database that is searchable by
gene name and by protein domain content. This database
will serve as a resource for the community for easy com-
parison of gene expression in the cell lines versus human
and mouse primary neutrophils, and as a reference for im-
proving gene perturbation strategies in neutrophil models.
Results and discussion
Comparison of commonly used differentiation protocols
Since neutrophilic differentiation is often associated with
increased cell death, we set out to determine which dif-
ferentiation protocol produces the most highly penetrant
differentiation while maintaining high cell viability. We
compared the most commonly used differentiation
agents in PLB-985 cells by measuring their ability to in-
duce expression of neutrophil surface markers and re-
duce proliferation while maintaining cell viability.
Initially, we compared differentiation for 6 days with
DMSO, ATRA (with 0.5% N,N-Dimethyl formamide
(DMF)) and dbcAMP [11, 25, 26].
To assess differentiation, we measured both early and
late differentiation markers. We chose CD11b (Integrin
Alpha M, ITGAM) as an early marker, since it begins to
appear within 3 days of differentiation with DMSO [27],
and FPR1 as a late neutrophil differentiation marker
since it is usually only detectable after 5 or 6 days of dif-
ferentiation. We measured both markers by flow cytom-
etry, using a monoclonal antibody against CD11b and a
fluorescent peptide ligand for FPR1 (FLPEP). An isotype
control for the CD11b antibody showed no staining
(data not shown). While undifferentiated cells did not
express CD11b or FPR1, a substantial percentage of cells
expressed both markers when treated with any of the
three differentiation inducers (Fig. 1a, Additional file 1: a
and b). Treatment with either DMSO or ATRA with
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DMF caused efficient expression of CD11b, while
dbcAMP only weakly induced this early differentiation
marker (Fig. 1a, Additional file 1: a). FPR1 was induced
with partial penetrance by all differentiation agents.
DMSO and dbcAMP gave the highest fractions of posi-
tive cells, but a sizeable fraction of cells with low or
undetectable receptor levels also remained (Fig. 1b,
Additional file 1: b, and Table 1). We also analyzed
differentiation with ATRA and DMF independently,
but their combination resulted in higher levels of
both CD11b and FPR1 than either compound on its
own (Additional file 1).
We measured the loss of cell viability by staining cells
with the NucRed Dead 647 reagent, which binds to
DNA in cells with compromised plasma membrane in-
tegrity. While DMSO caused little if any apparent cell
death, ATRA with DMF and dbcAMP each resulted in
about 50% inviability in the cell population (Fig. 1c and
Table 1). We also monitored cell proliferation by
counting viable cells using the trypan blue exclusion
method. All three treatments reduced proliferation, with
dbcAMP acting the most rapidly (Fig. 1d). However, by
day 6, the number of cells in the ATRA with DMF and
dbcAMP conditions had markedly decreased, consistent
with high rates of cell death. These results also coincide
with reports from the initial characterization of the
PLB-985 cell line [11].
While our initial results indicated that DMSO is the
most suitable agent for inducing neutrophil marker ex-
pression without hampering cell viability, we wanted to
explore variations of the protocol that might further im-
prove differentiation efficiency. We pursued combinations
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Fig. 1 DMSO-based differentiation protocol gives the best differentiation potential based on expression of differentiation markers and cell viability.
PLB-985 cells were differentiated into a neutrophil-like state by culturing in different media (DMSO, ATRA + DMF, or dbcAMP) for 6 days.
Undifferentiated cells were also analyzed. Cells were stained with an antibody against CD11b, chosen as an early differentiation marker
(a), with FLPEP (a fluorescent ligand of FPR1), chosen as a late differentiation marker (b), or with NucRed Dead 647 Probe, to measure
cell death (c). Samples were measured by cytometry and data was analyzed using MATLAB. d Cell growth was monitored at days zero,
three, and six of the differentiation protocols, using the trypan blue dye exclusion test. The number of cells were normalized to the initial
number of cells. These experiments were performed three times and a representative experiment is shown
Rincón et al. BMC Genomics  (2018) 19:573 Page 3 of 17
of DMSO, ATRA [28] and CA [22], as these have been re-
ported to improve differentiation. However, we observed
increased cell death and marginal improvement of FPR1
expression at best compared to DMSO alone (Table 1). In
an attempt to decrease cell death while still inducing dif-
ferentiation [29], we limited induction with ATRA to 12 h
followed by DMSO differentiation media for 5 days. How-
ever, the fraction of cells expressing FPR1 was no higher
than for DMSO alone (data not shown).
Replacing serum with Nutridoma during differentiation
increases FPR1 surface expression and chemotactic
efficiency
We also tested the effects of serum and serum replace-
ment on differentiation. High concentrations of serum
have been reported to inhibit differentiation [23].
However, the cell death rate increases markedly under
serum-free conditions [23]. Nutridoma, a serum free dif-
ferentiation supplement, has been reported to improve
cell differentiation while providing serum-like support of
cell viability [23, 30]. To test how serum concentration
and Nutridoma affect differentiation in PLB-985 cells,
we analyzed upregulation of FPR1 upon differentiation
in media containing DMSO, 0.5% fetal bovine serum
(FBS), and 2% Nutridoma. Surprisingly, replacing serum
with Nutridoma increased the percentage of cells that
express FPR1 by approximately 20% compared to DMSO
alone (Table 1 and Fig. 2a), while cell viability remained
similar to that of non-differentiated cells (Table 1). Con-
sistent with our FPR1 results, we observed that the pres-
ence of Nutridoma in the differentiation media also
increased the surface expression of CD11b (Fig. 2b). We
also validated the Nutridoma differentiation protocol in
HL-60 cells, where we saw similar increases in CD11b
and FPR1 surface expression (Additional file 2).
Next, we wanted to determine if the increase in
CD11b- and FPR1-expressing cells is correlated with a
more general increase in the functional maturation of
the cell population. With this in mind, we tested three
major behaviors associated with neutrophilic differenti-
ation: chemotaxis, phagocytosis and oxidative burst. We
used an automated chemotaxis assay to measure the re-
sponse of PLB-985 cells to a gradient of fMLF, an FPR1
ligand [25]. When cells were differentiated with DMSO
supplemented with Nutridoma and 0.5% FBS, we ob-
served a statistically significant increase (approximately
30%) in the directional accuracy of chemotaxis, validat-
ing the efficacy of this differentiation media (Fig. 2c).
We measured phagocytosis using pHrodo Green labeled
dead Staphylococcus aureus bioparticles. The addition of
Nutridoma to the differentiation media resulted in a
higher percentage of cells phagocytosing pHrodo-labeled
particles (Fig. 2d, Additional file 1: c). To quantify oxida-
tive burst, we measured the ability of PLB-985 cells to
produce reactive oxygen species using the nitroblue
tetrazolium (NBT) reduction assay. In response to
stimulation with either PMA or fMLF, a higher fraction
of cells differentiated with Nutridoma generated an oxi-
dative burst response, as measured by reduction of NBT
(Fig. 2e). Thus, in addition to increasing the surface ex-
pression of neutrophil markers, the Nutridoma differen-
tiation protocol results in increased responsiveness for
chemotaxis, phagocytosis, and oxidative burst.
To further assess the degree of differentiation, we
assessed nuclear size and morphology by imaging
Hoechst-stained nuclei. Although differentiation of the
cell line did not recapitulate the lobed morphology of
primary neutrophils, it resulted in bean shaped or
partially lobed nuclei (Additional file 3). Also, as ex-
pected, the nuclear size decreased after each of the
differentiation protocols. Somewhat surprisingly, this
decrease was smaller using the Nutridoma differenti-
ation protocol.
Finally, we wanted to compare the results obtained
with the PLB-985 cell line to primary neutrophils as a
benchmark for the validation of the differentiated cell
Table 1 PLB-985 cell death and expression of FPR1 under several differentiation inducer agents
In NucRed negative population
Differentiation protocol % Cells expressing FPR1 Mean Fluorescence Intensity for FPR1 % Cell death (NucRed Dead +)
Undifferentiated cells 4 41 10
DMSO 48 100 8
ATRA + DMF 27 78 44
dbcAMP 75 382 58
DMSO + ATRA 6 47.4 66
DMSO + ATRA + CA 52 142a 73
DMSO + Nutridoma CS 70 292.5 10
aAutofluorescence in non-stained samples is very high, probably due to CA
PLB-985 cells were differentiated into a neutrophil-like state by culturing in the indicated different media for 6 days. Undifferentiated cells were also analyzed.
Cells were stained with NucRed Deatd 647 Probe to measure cell death and with FLPEP, a fluorescent ligand of FPR1. Samples were measured by cytometry and
data was analyzed using MATLAB. For the mean fluorescence intensity (MFI), values were normalized against the MFI of the sample of cells differentiated only
with DMSO
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line. We isolated highly purified neutrophils from whole
human blood by immunomagnetic negative selection,
and performed cell surface staining and functional as-
says. The primary neutrophils showed highly uniform
expression of CD11b and FPR1, with CD11b expression
exceeding that of the cell line, but FPR1 expression actu-
ally being lower than that of the highest expressing
PLB-985 cells (Fig. 3a and b). The primary neutrophils
efficiently phagocytosed pHrodo-labeled S. aureus parti-
cles, but at a level that was similar to that observed for
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Fig. 2 Replacing serum with Nutridoma during differentiation increases FPR1 surface expression and chemotactic efficiency. PLB-985 cells were
differentiated into a neutrophil-like state by culturing in media supplemented with 1.3% DMSO and 9% FBS or supplemented with 1.3% DMSO,
2% Nutridoma and 0.5% FBS, for 6 days. Then cells were stained with FLPEP (a) or an antibody against CD11b (b) and measured by cytometry.
Data was analyzed using MATLAB. The experiment was repeated three times and a representative experiment is shown. (c) Cells differentiated as
in (a) and (b) were plated under agarose and analyzed in an automated chemotaxis assay by time-lapse microscopy with chemoattractant uncaging
of Nv-fMLF. A cell directionality parameter measuring the angular bias of cell movement towards the gradient source is shown. This experiment was
performed three times. Error bars represent the standard error of the mean. Images and statistics were processed using custom MATLAB software.
Asterisk indicates a p-value of less than 0.05 using a t-test. d Cells differentiated as in (a) and (b) were mixed in suspension with pHrodo Green-labeled
dead Staphylococcus aureus bioparticles for 2 h at 37 degrees. Phagocytosis of the particles was then analyzed by cytometry. e PLB-985 cells were
differentiated into a neutrophil-like state as in (a) and (b). Cells were then incubated with NBT solution and 100 ng/mL of PMA or 1 μM fMLF, at 37 °C
for 15 min, and measured by cytometry
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Fig. 3 Comparison of differentiated PLB-985 cells with primary neutrophils. a Undifferentiated PLB-985 cells, PLB-985 cells differentiated with DMSO
and Nutridoma, and primary neutrophils were stained with antibody against CD11b and analyzed by cytometry. Staining of primary neutrophils with
an isotype control antibody is also shown. b The same cell samples were stained with FLPEP and analyzed by cytometry. Unstained samples are also
shown for comparison. c Phagocytosis of pHrodo Green-labeled dead Staphylococcus aureus bioparticles. Negative controls in which no particles were
present are also shown. d-f Differentiated PLB-985 cells and primary neutrophils were plated under agarose and analyzed in an automated chemotaxis
assay by time-lapse microscopy with chemoattractant uncaging of Nv-fMLF. Mean cell speed was measured both before (d) and after (e) generation
of an fMLF gradient. A cell directionality parameter measuring the angular bias of cell movement towards the gradient source is shown (f). An angular
bias of 90 degrees indicates perfect directionality, and zero degrees indicates random orientation. This experiment was performed three times. Error
bars represent the standard error of the mean. Asterisk indicates a p-value of less than 0.05 and double asterisks indicate a p-value of less than 0.01
using a t-test. g Histograms of the instantaneous directionality of individual cells is shown for the same experiments analyzed in (f). Here an angle of
zero indicates optimal directionality, and 180 degrees indicates movement in the opposite direction. A third curve (yellow) indicates simulated data for
a population of neutrophils in which only 70% of cells express the receptor FPR1
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PLB-985 cells differentiated with DMSO and Nutridoma
(Fig. 3c). Finally, we assessed chemotaxis. Primary neu-
trophils showed markedly lower basal motility and
slightly reduced stimulated speed when compared to dif-
ferentiated PLB-985 cells (Fig. 3d and e). However, their
chemotactic responses were strong, with a marked in-
crease in speed after stimulation (Fig. 3d and e) and
higher average directional accuracy than the cell line
(Fig. 3f ). Interestingly, we found that the difference in
chemotactic directionality could be explained by the het-
erogeneous expression of FPR1 in the cell line. Since
only about 70% of cells differentiated with DMSO and
Nutridoma express FPR1 (Fig. 1b, Table 1), we simulated
the chemotaxis of a mixed cell population in which 70%
chemotax equivalently to primary neutrophils and 30%
move with random directionality. This simulated data
closely matched the observed directionality of the differ-
entiated PLB-985 cells (Fig. 3g).
The presence of Nutridoma, rather than the absence of
serum, is responsible for increased FPR1 surface expression
and chemotactic efficiency
We wanted to determine whether the increased FPR1
expression was due to the reduced serum levels or a
positive effect from the Nutridoma supplement. To test
this, we titrated the FBS concentration in differentiation
media containing fixed concentrations of DMSO and
Nutridoma. We found that most of the increase in FPR1
expression was due to the presence of Nutridoma, and
FPR1 expression depended only weakly on the concen-
tration of FBS. However, 0.5% FBS gave a slightly higher
population of FPR1 positive cells (Additional file 4: a),
consistent with previous reports [23].
Although the molecular components of Nutridoma are
proprietary, we tested the cytokine G-CSF as a candidate
active component. G-CSF is a primary regulator of mye-
loid cell differentiation in humans, and it has been
shown to promote neutrophilic differentiation in vitro in
combination with ATRA [24, 31]. To investigate whether
G-CSF could be the factor in Nutridoma causing the
cells to upregulate FPR1 expression, we differentiated
PLB-985 cells using DMSO combined with either Nutri-
doma or G-CSF [32]. However, based on CD11b and
FPR1 expression, G-CSF was not only unable to substi-
tute for Nutridoma, but it actually inhibited DMSO-me-
diated differentiation (Additional file 4: b and c). This
result was surprising, given the role of G-CSF in neutro-
phil differentiation in vivo. However, G-CSF acts on
multiple cell types in coordination with other stimuli,
and it is possible that in this context it is promoting for-
mation of an alternate or intermediate cell state. Based
on the above results, we have adopted an optimized
differentiation protocol with DMSO in media supple-
mented with 0.5% FBS and 2% Nutridoma.
Transcriptional profiles of HL-60 and PLB-985 cells
Having validated an optimal differentiation protocol
using DMSO and Nutridoma based on expression of
surface markers, we next wanted to compare global gene
expression in myeloid cell lines to that of primary neu-
trophils. While another group had previously compared
gene expression in HL-60 cells differentiated with either
DMSO or ATRA using microarrays [33], no analysis of
HL-60 or PLB-985 cell differentiation had yet been com-
pleted with the depth and precision that is now possible
with RNA-seq. To this end, we extracted total RNA
from the cell lines before and after differentiation (as
well as at two intermediate time points for PLB-985
cells) and processed it for RNA-seq (Fig. 4a). To account
for measurement noise and day-to-day variability, we re-
peated the RNA-Seq experiment on two independent
days separated by more than 2 months. For comparison,
we collated raw datasets for primary human neutrophils
[34–36], undifferentiated HL-60 cells [37], and primary
mouse neutrophils [38, 39] from previously published
studies [40]. We re-analyzed these data sets along-side
our own data using identical parameters and normalization
(see Methods for details, and Additional file 5 and
Additional file 6 for the full data set).
To compare human and mouse neutrophil transcrip-
tomes, we restricted our analysis to the set of genes
mapped as homologs between the two organisms in
NCBI’s Homologene database [40]. We then performed
unbiased hierarchical clustering of the different tran-
scriptomes using the Spearman rank correlation coeffi-
cient as a similarity metric (Fig. 4b) and a principal
component analysis (Additional file 7). As expected, in
both analyses the human primary neutrophil datasets
clustered together, as did the mouse primary neutrophil
datasets. The cell line datasets also clustered together,
with clear subclusters for undifferentiated and differenti-
ated subsets. The latter lie closer to the human primary
neutrophil datasets. As one point of caution, the datasets
reanalyzed in this study used different protocols for neu-
trophil isolation, and the presence of some immature
cells in the Taylor et al. study, which used density centri-
fugation of bone marrow cells, cannot be excluded. A
comparison of the neutrophil isolation methods and
RNA processing strategies is presented in Table 2.
Differentiation results in a neutrophil-like gene expression
pattern
The differentiation of the cell lines with either DMSO
or DMSO and Nutridoma resulted in large-scale
changes in gene expression (Fig. 5a) and increased
the correlation of their gene expression profiles with
that of primary human neutrophils (Fig. 4b). The cor-
relation strength increased steadily throughout differ-
entiation, with the biggest change occurring in the
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first 2 days (Figs. 4b and 5b). To compare the global
change in transcription during differentiation, we
plotted density-colored scatter plots comparing pri-
mary neutrophil data for protein-coding genes to that
of undifferentiated or differentiated (with DMSO and
Nutridoma) PLB-985 cells (Fig. 5c). The plots re-
vealed a global increase in correlation strength, with
the bulk of points falling in a tighter more elongated
cloud along the diagonal after differentiation. We saw
the same effect when HL-60 cell datasets were com-
pared to primary neutrophil data (Additional file 8).
As both differentiated human cell lines and primary
mouse neutrophils serve as models for human neutro-
phils, we asked which gene expression pattern correlates
more strongly with that of human neutrophils. While
both expression patterns correlated more strongly with
the human neutrophil data than the undifferentiated cell
line data did, we noted that the differentiated cell line
data actually correlated more strongly than the mouse
neutrophil data (Fig. 4b). These results should be taken
with some caution, as there may be systematic differ-
ences due to different experimental protocols or imper-
fect mapping of homologs. However, based on global
gene expression, our study suggests that the differenti-
ated cell lines resemble human neutrophils as much, or
even more so, than mouse neutrophils do. We also
noted that while we did see systematic differences
between datasets collected by different groups, these dif-
ferences were generally small relative to the differences
between cell types or differentiation states. Indeed, every
individual human neutrophil dataset correlated better
with the differentiated cell lines than it did with the
mouse neutrophil datasets (Fig. 4b).
Nutridoma affects gene expression during differentiation
subtly, but consistently in HL-60 and PLB-985 cells
Since the presence of Nutridoma increased cell surface
expression of FPR1 and CD11b during differentiation
(Table 1, Fig. 2a, b), we investigated whether Nutridoma
broadly increases neutrophil-like differentiation at the
level of transcription. First, we compared the expression
of FPR1 in our RNA-seq data to surface expression
data at different time points during differentiation
(Additional file 9: a). Consistent with our earlier obser-
vations, the addition of Nutridoma increased the FPR1
surface expression level markedly between day 4 and day
6. However, while Nutridoma also increased FPR1 expres-
sion at the mRNA level, this change was considerably
smaller than what we observed at the cell surface protein
level (Additional file 9: a). These results suggest that
Nutridoma may influence the cells at the protein level to
make them more functionally mature, such as an effect on
translation or vesicular trafficking of receptors to the
plasma membrane.
Table 2 Overview of processing of cells and RNA for RNA-seq data sets analyzed in this study
Data set Neutrophil isolation RNA enrichment Sequencing method Read mapping and analysis
this study N/A polyA enrichment Illimuna HiSeq, 1 × 75 bp All data sets were reanalyzed
in this study with uniform
read mapping and analysis
methods. See Methods
for details
Cusanovich et al N/A polyA enrichment Illumina NextSeq, 1 × 75 bp
Jiang et al density gradient sedimentation
(Polymorphprep)
polyA enrichment Illumina HiSeq, 2 × 75 bp
paired end
Thomas et al. (samples 1 and 3) negative selection polyA enrichment Illimuna HiSeq, 1 × 50 bp
Thomas et al. (samples 2 and 4) density gradient sedimentation
(Polymorphprep)
polyA enrichment Illimuna HiSeq, 1 × 50 bp
Wright et al density gradient sedimentation
(Polymorphprep)
polyA enrichment Illimuna HiSeq, 1 × 50 bp
Taylor et al density gradient sedimentation
(Percoll)
polyA enrichment Illimuna HiSeq, 1 × 50 bp
Coffelt et al positive selection (Ly6G+) polyA enrichment Illimuna HiSeq, 1 × 50 bp
The methods of neutrophil isolation (for studies involving primary neutrophils), mRNA enrichment, and sequencing are indicated in the table. All data sets were
re-analyzed with a uniform computational pipeline (see Methods for details) to avoid potential systematic differences due to analysis methods
(See figure on previous page.)
Fig. 4 Transcriptional profiles of HL-60 and PLB-985 cells before and after differentiation and comparison to that of primary neutrophils. a Experimental
design: HL-60 and PLB-985 cells were differentiated by culturing in media supplemented with 1.3% DMSO and 9% FBS or 1.3% DMSO, 2% Nutridoma and
0.5% FBS. Total RNA of cells harvested at the indicated time points was isolated. PolyA enrichment and RNA-seq were performed by Applied Biological
Materials Inc. through their Total RNA Sequencing service. RNA-seq data was subjected to our analysis pipeline as described in Methods. b Heat map of
Spearman correlations between transcriptional profiles of undifferentiated and differentiated HL-60 and PLB-985 cells and human and mouse primary
neutrophils, organized by unbiased hierarchical clustering. Color bar indicates correlation strength. Each row/column represents an independent sample.
For the cell line data, the labels d2, d4, and d6 indicate 2, 4, and 6 days of differentiation, respectively. For the Thomas et al. data, the labels s1, s2, s3, and
s4 indicate sample numbers, which correspond to the sample numbers in Table 2
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Next, we compared global gene expression patterns in
cells differentiated with DMSO or with the combination
of DMSO and Nutridoma. Although each protocol re-
sulted in gene expression patterns that correlated ap-
proximately equally well with the primary human
neutrophil data (Fig. 4b), we wanted to check if there
were reproducible differences in gene expression between
the two conditions. To do this, we compared the log10
fold-changes in expression between the two protocols and
compared these changes from each of our two replicates
of the RNA-Seq experiments. Even though the differences
in gene expression were typically modest, they did correl-
ate between the two replicates (Additional file 9: b, c). A
further analysis of gene annotations using the DAVID
functional annotation tool [41], revealed that the set of
genes upregulated during differentiation in the presence
of Nutridoma (relative to differentiation with DMSO only)
are enriched for several annotations including the Gene
Ontology (GO) Biological Process annotation of “immune
response”, the GO Cellular Compartment annotation
“plasma membrane”, and STAT5B transcription factor
binding sites (Additional file 10).
Together our observations indicate that, although the
correlation in gene expression between primary neutro-
phils and PLB-985 cells differentiated with or without
Nutridoma is roughly equivalent, the presence of this
supplement in the differentiation media subtly, but re-
producibly affects gene expression at the mRNA level. In
addition, Nutridoma also causes non-transcriptional
changes which increase the cell surface expression of the
neutrophil markers FPR1 and CD11b.
SNP analysis confirms that PLB-985 is genetically identical
to HL-60
Although the PLB-985 cell line was originally described
as a distinct cell line established from an acute myeloid
leukemia patient in 1985 [11], Drexler and colleagues
more recently reported that this cell line is actually a
subclone of the HL-60 cell line [12]. The description of
PLB-985 as a misidentified cell line can be found in the
Fig. 5 PLB-985 cell differentiation results in neutrophil-like gene expression patterns. a Histogram of log10 fold expression changes between replicate
measurements of undifferentiated PLB-985 cells (ND), and between undifferentiated cells and those differentiated with either 1.3% DMSO and 9% FBS
(DMSO) or DMSO + 2% Nutridoma + 0.5% FBS (Nutri). b Spearman’s correlation coefficients for the similarity between transcriptional profiles of primary
human neutrophils and PLB-985 cells at 0, 2, 4 and 6 days post differentiation with DMSO + 2% Nutridoma + 0.5% FBS. c Density-colored scatter plots
of expression values (normalized FPKM on a log10 scale) for protein-coding genes for primary human neutrophils versus undifferentiated PLB-985 cells
(left) or those differentiated with DMSO + Nutridoma (right)
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National Center for Biotechnology Information (NCBI)
BioSample database (https://www.ncbi.nlm.nih.gov/biosam-
ple/3151776) or in the ICLAC Database of Cross-contami-
nated or Misidentified Cell Lines (http://iclac.org/
databases/cross-contaminations/). The RNA-seq data that
we generated for both cell lines allowed us to investigate
this reclassification. We used the Genome Analysis Tool-
kit (GATK) pipeline to call variant genotypes for each
sample from our RNA-Seq raw data and from the primary
neutrophil data which could serve as a negative control
[42]. As expected, we found identical genotypes for repli-
cate samples, and distinct genotypes for primary neutro-
phil data from different donors. Consistent with previous
reports, we also found identical genotypes for the
PLB-985 and HL-60 cell lines (Additional file 11). How-
ever, even though they are genetically identical, our
RNA-Seq data indicates that there are reproducible gene
expression differences between PLB-985 and HL-60 cells.
We conclude that PLB-985 is a sub-line of HL-60 with
some differences in gene expression which may make it
better suited for some experimental investigations.
A searchable database of neutrophil and neutrophil-like
cell line gene expression
A major goal of our study was to create an accessible
database of gene expression for neutrophils and
neutrophil-like cell lines. Such a tool would allow re-
searchers to assess the expression of gene families of
interest, or compare gene expression in cell lines to that
in primary neutrophils to verify similarities or identify
key differences. To highlight how our compiled datasets
can be used, we analyzed expression levels of four sets
of genes known to be important for neutrophil func-
tions: cell surface receptors, proteins involved in reactive
oxygen production, guanine nucleotide exchange factors
(GEFs) for Rho family GTPases, and adhesion receptors
(Fig. 6a-d). In each case, differentiation broadly in-
creased the similarity in gene expression of these gene
sets between the cell lines and primary neutrophils, in-
cluding upregulation of chemoattractant receptors, oxi-
dative burst-related genes, adhesion molecules, and
other neutrophil-associated genes (Fig. 6a-d). In con-
trast, related oxidase components and adhesion recep-
tors not associated with neutrophils remained lowly
expressed (Fig. 6b, d). However, key differences between
the cell lines and primary neutrophils are also apparent.
For example, the formyl peptide receptor FPR1 is highly
expressed in the cell lines, but expression of the IL-8
cytokine receptor CXCR1 is lacking (Fig. 6a). Similarly,
many GEFs including PREX1, ARHGEF2 (also known as
GEF-H1), VAV1, and ARHGEF6 (also known as alpha-PIX)
are expressed at levels close to or equal to that found in
neutrophils. However, DOCK5 and PLEKHG3 are expressed
at much lower levels.
Finally, to make our RNA-seq results easily accessible
to other researchers, we published a comprehensive,
interactive database on our website (http://collinslab.ucda
vis.edu/neutrophilgeneexpression/) (Fig. 6e). This database
is searchable by gene id, symbol, or protein domain and
can be sorted by expression level in any of the cell types.
In addition to our own RNA-seq data, we included
published RNA-seq data for primary human and Mus
musculus (mouse) neutrophils, and links to mouse
and Dictyostelium discoideum homologs. D. discoi-
deum is an amoeboid protozoan and a valuable model
organism for the study of chemotaxis and phagocyt-
osis. This complete merged data set is also available
as a table in Additional file 12.
Conclusions
We first compared established differentiation protocols
for myeloid cell lines, with a focus on maximizing cell
surface expression of neutrophil markers without com-
promising cell viability. Our study verifies that a
DMSO-based differentiation protocol for HL-60 and
PLB-985 cell lines gives superior differentiation and cell
viability relative to other common protocols, and indi-
cates that addition of Nutridoma may be preferable for
studies of chemotaxis, phagocytosis and oxidative burst.
Our RNA-seq data allowed us to generate a map of gene
expression in differentiated HL-60 and PLB-985 cells
which could be combined with primary human and
mouse neutrophil data from the literature. We annotated
this map, creating a database that is searchable by gene
name and by protein domain content to allow rapid in-
terrogation of gene expression in neutrophils and
neutrophil-like cell lines. Our neutrophil gene expres-
sion database will be a valuable tool to identify similar-
ities and differences in gene expression between the cell
lines and primary neutrophils, to compare expression
levels for genes of interest, and to improve the design of
tools for genetic perturbations.
Methods
Reagents and antibodies
DMSO, ATRA, CA, dbcAMP, PMA, fMLF and NBT
were purchased from Sigma; Nutridoma-CS from Roche,
Trypan Blue solution from Corning, G-CSF from Ap-
plied Biological Materials (abm), FLPEP (catalog #
F1314); Sytox Blue (catalog #S11348), TO-PRO3 Ready
Flow dead cell stain (catalog #R37170), and NucRed
Dead 647 (catalog #R37113) from Life Technologies; and
Anti-CD11b-APC (Clone ICRF44, catalog # 301309),
isotype control mouse IgG1κ (Clone MOPC-21, catalog
# 400107) and Fc Receptor Blocking Solution (catalog #
422302) from Biolegend.
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Fig. 6 (See legend on next page.)
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Cell culture and differentiation
HL-60 and PLB-985 cells were obtained as a gift from the
laboratory of Dr. Orion Weiner. Generation of the stable
cell lines expressing fusions of histone H2B to mTur-
quoise or mCherry were described elsewhere [25]. The
PLB-985 cell line expressing H2B-mCherry was used for
all the experiments described throughout the manuscript.
Cells were cultured in complete media [RPMI 1640 with
HEPES and GlutaMAX (Gibco, catalog # 72400–047) sup-
plemented with 9% fetal bovine serum (FBS) as well as
streptomycin (100 mg/mL) and penicillin (100 U/mL) (P/
S)] at 37 °C in a humidified atmosphere with 5% CO2. Cell
cultures were passaged two to three times per week, main-
taining cell densities between 105 and 2 × 106 cells per ml.
The cells were differentiated into a neutrophil-like state
by culturing at an initial density of 2 × 105 using one of
seven media recipes: a) RPMI 1640 complete media sup-
plemented with 1.3% DMSO for 6 days; b) RPMI 1640
media supplemented with 5% FBS, 0.5% DMF and 2 uM
ATRA (renewed on day 3 of the 6-day differentiation
period); c) RPMI 1640 complete media supplemented with
750 uM dbcAMP for 6 days; d) RPMI 1640 complete
media supplemented 1.3% DMSO and 2 uM ATRA for
6 days; e) RPMI 1640 complete media supplemented with
1.3% DMSO, 2 uM ATRA and 52 uM CA for 6 days; f )
RPMI 1640 media supplemented with different FBS con-
centrations (0.5, 2, 5 or 10%), 1.3% DMSO and 2% Nutri-
doma for 6 days; g) RPMI 1640 media supplemented with
0.5% FBS, 1.3% DMSO and 30 ng/ml G-CSF for 6 days.
Human primary neutrophil isolation
Ethical approval for the study of neutrophils from adult
healthy controls was granted by the Institutional Review
Board (IRB) from the University of California, Davis. All
participants gave written, informed consent. Blood was
collected by finger prick using a microlet lancing device
to isolate small drops of blood. Neutrophils were iso-
lated using negative selection with the EasySep Direct
Human Neutrophil isolation kit (StemCell), following
the manufacturer’s instructions.
Nuclear area calculation
Fluorescence images were acquired using a Nikon
Ti-E inverted microscope with a 20× (0.75 NA) Plan
Apochromat objective with an optovar for an additional
1.5× magnification. DNA was detected using mCherry
tagged histone H2B for cell lines and Hoechst staining for
primary human neutrophils. All cell types were stained
with Sytox Blue to determine viability. Viability scoring,
nuclear segmentation and calculation of nuclear areas
were carried out in MATLAB using custom software.
Briefly, nuclei were segmented using an intensity thresh-
old. A minimum area threshold of 100 pixels (~44uM)
was implemented to filter out debris. Dead cells (nuclei
positive for Sytox stain) were also excluded.
Immunolabeling and cytometry
Differentiation of PLB-985 cells into a neutrophil-like
state was assessed by measuring the levels of CD11b and
the formyl peptide receptor FPR1 on the cell surface.
For detection of CD11b, cells were harvested, washed
with phosphate-buffered saline (PBS) and stained with
primary antibody antiCD11b-APC (clone ICRF44) along
with Fc Receptor Blocking Solution (for 45 min at 4 °C
in FACS buffer (0.5% bovine serum albumin and 0.05%
sodium azide in PBS). After fluorescent labeling, the
samples were washed and acquired with the BD FACS-
Canto II flow cytometer (BD Biosciences, Franklin Lakes,
NJ). Relative levels of FPR1 were assessed by binding of
N-formyl-norleucyl-leucyl-phenylalanyl-norleucyl-tyrosyl-
lysine-fluorescein (FLPEP) (Life Technologies product
number F1314), a fluorescent ligand of the receptor. Cells
were mixed with ice cold media containing FLPEP to give
a final concentration of 10 nM, placed on ice for 10 min,
and acquired with the BD FACSCanto II flow cyt-
ometer. For one condition (DMSO+ATRA+CA), cellu-
lar autofluorescence was high in the fluorescein
channel, and it was corrected by subtracting the mean
autofluorescence from the unstained control samples.
We measured cell death using NucRed Dead 647
Probe (Life Technologies, product number R37113) or
TO-PRO3 (R37170) according to the manufacturer’s
protocol. FACS data was analyzed using MATLAB
(Mathworks, Inc.). To determine the percentage of
cells expressing the target, we set thresholds using an
appropriate negative control (isotype immunoglobu-
lins) for CD11b or non-stained cells for FLPEP and
NucRed Dead 647.
(See figure on previous page.)
Fig. 6 An easily searchable online database of neutrophil and neutrophil-like cell gene expression. a-d Gene expression data is shown (normalized
FPKM data on a log10 scale) for the indicated genes in undifferentiated PLB-985 cells, PLB-985 cells differentiated with the DMSO only protocol, PLB-
985 cells differentiated with the Nutridoma + DMSO protocol, and primary human neutrophils (collated from 3 published studies). Shown is data for
select receptors (a), genes related to the production of reactive oxygen species (b), select guanine nucleotide exchange factors (GEFs) for Rho Family
GTPases (c) and adhesion molecules (d). e Our collated RNA-seq data is available in an easily searchable form on our lab website: http://
collinslab.ucdavis.edu/neutrophilgeneexpression/. Data can be searched by gene name, or by the presence of specific PFAM domains of
interest. Data can also be sorted by expression level in any of the samples. In this example, we identify the top 10 genes containing PKINASE
domain, ordered by expression level in primary human neutrophils
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Cell growth
To measure cell proliferation, cells were counted at day
three and six of the differentiation protocols, using the
trypan blue dye exclusion test. The number of cells were
normalized against the initial number of cells.
Chemotaxis assay
The chemotaxis assay was performed as previously de-
scribed [25]. Briefly, differentiated PLB-985 cells were
plated in 96-well plates under low melting temperature
agarose and imaged by time-lapse microscopy with
chemoattractant uncaging. A caged UV sensitive deriva-
tive N-nitroveratryl derivative (Nv-fMLF) of N-formyl-
methioninealanine-phenylalanine was used, and UV
photo-uncaging was performed to generate chemical gra-
dients. Image processing and statistical analyses of chemo-
taxis were performed using custom MATLAB software.
Phagocytosis assay
Cells were mixed in suspension with pHrodo Green-la-
beled dead Staphylococcus aureus bioparticles for 2 h at
37 degrees. The pHrodo Green dye markedly increases
fluorescence upon reaching an acidic environment such as
that of the phagosome, which greatly limits the contribu-
tion of non-internalized particles to the fluorescence sig-
nal. Phagocytosis of the particles was analyzed by
cytometry with the BD FACSCanto II flow cytometer.
NBT reduction assay
Differentiated cells were harvested and resuspended in
Leibovitz’s L-15 media (ThermoFisher, product number
11415–064) supplemented with FBS. Cells were then
mixed with ice cold media containing 2X NBT solution
(Sigma, product number N5514) and 200 ng/ml of phor-
bol 12-myristate 13- acetate (PMA) or 2 μM of fMLF in
L-15 media and incubated at 37 °C for 15 min. After in-
cubation, deposition of purple formazan granules (from
the reduction of NBT) was acquired with the BD FACS-
Canto II flow cytometer.
RNA-seq analysis pipeline
Total RNA was isolated using the RNeasy Plus Mini Kit
(Qiagen) according to the manufacturer’s protocol. PolyA
enrichment and RNA-seq were performed by Applied Bio-
logical Materials Inc. through their Total RNA Sequencing
service. The samples were subjected to polyA enrichment
followed by fragmentation, first and second strand synthe-
sis, adenylation of 3′ ends, adapter ligation, DNA fragment
enrichment, and real-time PCR quantification. For each
sample, over thirty million 1 × 75-base single-end reads
were produced on the Illumina NextSeq 500 platform.
Human raw RNA-seq reads were aligned to the GRCh38.p5
version of the human genome using the GENCODE
GRCh38 (release 24) genome annotations and the STAR
two-pass algorithm (STAR version 2.4) [43]. Mouse RNA-
seq reads were aligned to the GRCm38 version of the
mouse genome using the GENCODE M8 annotations.
Gene expression was quantified using the open-source soft-
ware Cufflinks (version 2.2.1) [44]. Gene expression was
normalized using the “uniform genes” strategy of Glusman
et al. [45]. Briefly, a set of “uniform genes” was defined as
all genes with expression levels between the 50th and 90th
percentile in all samples. A scaling factor was computed for
each dataset as the geometric mean of the expression levels
of these “uniform genes.” Each dataset was then normalized
by dividing by its own scaling factor and multiplying by the
mean scaling factor of the human datasets. Normalization,
comparison and correlation of the different transcriptomes,
and hierarchical clustering of the data, was done using
MATLAB. Log base 10 expression values were calculated
after normalization, and genes with zero read counts were
assigned a value of − 4 to avoid infinite values. Hierarchical
clustering was done using one minus the Spearman rank
correlation coefficient as the distance metric and average
linkage. Pairwise Spearman rank correlation coefficients
were displayed in the cluster heatmap. Principal component
analysis was performed using MATLAB’s “pca” function
with the default options. To avoid a large influence from
noise in lowly expressed genes, all log10 expression below
− 2 were set to − 2 for the principal component analysis.
For our final data tables, we averaged the data over repli-
cate samples using the geometric mean. For the primary hu-
man and mouse neutrophil datasets, we first averaged the
replicate measurement performed by each laboratory group
(note that the Thomas et al. [36] and Wright et al.
[35] datasets are from the same laboratory), and then
averaged over the different laboratories to give equal
weight to each lab to account for potential lab-to-lab
systematic differences.
For the density-colored scatter plots in Fig. 5a, the
averaged gene expression profiles were used. Only
protein-coding genes were included in the plot, based
on NCBI’s “Gene type” designations (18,976 genes)
[40]. Data for noncoding RNAs were much more vari-
able, perhaps in part due to the polyA enrichment step
of our experimental processing.
For the cluster of gene expression profiles in Fig. 4b and
the principal component analysis in Additional file 7, only
genes mapped between human and mouse as homologs in
NCBI’s Homologene database [40] were included.
Variant calling for genotyping was performed using
the GATK pipeline and the GATK best practices
guidelines [42]. After variant calling, the genotype
data was filtered to keep only loci with a read depth
of at least 10 in all samples and a quality score of greater
than 100. Genotypes were then compared to deter-
mine the fraction of loci with identical genotypes for
each pair of samples.
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Generation of the database
Normalized RNA-seq data (prepared as described above)
was compiled into a database using MySQL and published
on our website (collinslab.ucdavis.edu). Dictyostelium dis-
coidum homologs were downloaded from InParanoid
(http://inparanoid.sbc.su.se/cgi-bin/index.cgi).
Accession numbers
HL-60 and PLB-985 undifferentiated and differentiated
RNA-seq data were deposited at the NCBI Gene Expres-
sion Omnibus (GEO) database (Accession: GSE103706).
Previously published data for primary human neutro-
phils from the Wright et al. [GEO: GSE40548], Jiang et
al. [GEO: GSE66895], and Thomas et al. [GEO:
GSE70068] studies, for undifferentiated HL-60 cells from
the Cusanovich et al. study [GEO: GSE68103], and for
primary mouse neutrophils from the Taylor et al. [GEO:
GSE55090] and Coffelt et al. [GSE55633] studies were
downloaded from NCBI’s GEO database.
Additional files
Additional file 1: Comparison of cell surface marker expression with
different differentiation protocols. PLB-985 cells were differentiated into a
neutrophil-like state by culturing in media supplemented with 1.3% DMSO
and 2 μM ATRA for 4 days, 1.3% DMSO and 2 μM ATRA for 6 days, 0.5%
DMF for 6 days, 1 μM ATRA for 6 days, 2 μM ATRA for 6 days, or 0.5% DMF
and 2 μM ATRA for 6 days. Undifferentiated cells were also analyzed. Cells
were stained with an antibody against CD11b, chosen as an early
differentiation marker (a), or with FLPEP (a fluorescent ligand of
FPR1), as a late differentiation marker (b). (c) PLB-985 cells differentiated for
6 days with either 1.3% DMSO, 1.3% DMSO and 2% Nutridoma-CS, 0.5%
DMF and 2 μM ATRA, or dbcAMP were mixed in suspension with pHrodo
Green-labeled dead Staphylococcus aureus bioparticles for 2 hours at 37
degrees. Phagocytosis of the particles was then analyzed by cytometry and
data was analyzed using MATLAB. (PDF 162 kb)
Additional file 2: The effect of Nutridoma on surface marker expression
is also seen in HL-60 cells. HL-60 cells were differentiated into a neutrophil-like
state by culturing in media supplemented with 1.3% DMSO and 9% FBS or
supplemented with 1.3% DMSO, 2% Nutridoma and 0.5% FBS, for 6 days. Cells
were stained with an antibody against CD11b (a) or the fluorescent FPR1
ligand FLPEP and measured by cytometry. Undifferentiated cells were
also analyzed. Data was analyzed using MATLAB. (PDF 134 kb)
Additional file 3: Differentiation of PLB985 cells reduces nuclear area
and alters nuclear morphology. (a) Nuclear areas were measured by
fluorescence imaging of either histone H2B-mCherry for PLB-985 cells
or Hoechst-labeled DNA for primary neutrophils. A histogram of nuclear
areas for undifferentiated PLB-985 cells (blue; n = 6203), PLB-985 cells
differentiated with DMSO alone (red; n = 4338), PLB-985 cells differentiated
with DMSO + Nutridoma CS (yellow; n = 4393), PLB-985 cells differentiated
with DMF + ATRA (purple; n = 2386) and human primary neutrophils (green;
n = 2264). The X axis represents nuclear area in square pixels, where 1 pixel
= 0.4389 μm. Staining with Sytox Blue was used to exclude dead cells from
the analysis. (b-f) Representative images of nuclei where scale bar equals
20 μm. DNA is shown in red and Sytox Blue dye (a membrane impermeable
DNA-binding dye) is shown in green. (PDF 1850 kb)
Additional file 4: (a) PLB-985 cells were differentiated into a neutrophil-like
state by culturing in media supplemented with 1.3% DMSO, 2% Nutridoma
and the indicated percentage of FBS. Cells were stained with FLPEP and
measured by cytometry. (b-c) PLB-985 cells were differentiated into a
neutrophil-like state by culturing in media supplemented with 1.3%
DMSO 0.5% FBS and either 2% Nutridoma or 30 ng/mL G-CSF for
6 days. Cells were stained with anti-CD11b (b) or with FLPEP (c) and
measured by cytometry. Cytometry data was analyzed using MATLAB
in all the experiments. Data for the undifferentiated cells and those
differentiated with DMSO or DMSO + Nutridoma is the same as that
shown in Fig. 2. (PDF 158 kb)
Additional file 5: Full tables of processed gene expression values
measured by RNA-Seq in this study. This Excel file contains two sheets. The
first sheet contains FPKM gene expression values generated by Cufflinks for
all samples analyzed by RNA-Seq in this study. The second sheet contains
the log10-transformed normalized expression values. These values
were computed from the FPKM values as described in the Methods
section. (XLSX 15648 kb)
Additional file 6: Full tables of reanalyzed gene expression data for primary
neutrophils and HL-60 cells from previously published studies. This Excel file
contains four sheets. The first sheet contains FPKM gene expression values
generated by Cufflinks for all primary human neutrophil and HL-60 samples
reanalyzed in this study. The second sheet contains the corresponding log10-
transformed normalized expression values. The third sheet contains FPKM
gene expression values for all primary mouse neutrophil samples reanalyzed
in this study, and the fourth sheet contains the corresponding log10-
transformed normalized values. (XLSX 21707 kb)
Additional file 7: Principal component analysis of the gene expression
data analyzed in this study. Principal component analysis was carried out
using MATLAB’s “pca” function with the default options for all data sets
included in this study (the same data sets that are included in Fig. 4b).
Only log10 expression values for genes with both human and mouse
homologs were included for the analysis. To avoid a large influence from
noise in lowly expressed genes, all log10 expression below − 2 were set
to − 2 for this analysis. Shown is a scatter plot of the first two principal
components. Together, these two components explained 66% of the variance
in the data set. (PDF 357 kb)
Additional file 8: Similarity of gene expression between HL-60 cells and
primary human neutrophils. Density-colored scatter plots of expression
values (normalized FPKM on a log10 scale) for protein-coding genes for
primary human neutrophils versus undifferentiated HL-60 cells (left) or
those differentiated with DMSO + Nutridoma (right). (PDF 364 kb)
Additional file 9: Nutridoma affects gene expression during differentiation
subtly, but consistently in HL-60 and PLB-985 cells. (a) PLB-985 cells were
differentiated into a neutrophil-like state by culturing in media supplemented
with 1.3% DMSO, 2% Nutridoma and 0.5% FBS. At the indicated days post-
differentiation, cells were harvested and processed for RNA-seq analysis or
stained with FLPEP. Shown are the expression level of FPR1 at the mRNA
level (from our RNA-seq data) and at the surface of the cells (FLPEP staining).
Values for undifferentiated cells and for cell differentiated with 1.3% DMSO
and 9% FBS are shown for comparison. Values were normalized by the
values for the sample differentiated with only DMSO. (b) Density-colored
scatter plots of expression values (normalized FPKM on a log10 scale) for
protein-coding genes for HL-60 (left) or PLB-985 cells (right) cells differenti-
ated with DMSO + Nutridoma versus those differentiated with DMSO. These
data represent the averages of two replicate experiments. (c) Density-
colored scatter plots of log10 fold-changes between the two protocols
(subtracting DMSO values from DMSO + Nutridoma) comparing each of
our two replicates of the RNA-Seq experiments for HL-60 (left) or PLB-985
(right) cells. To avoid noise from lowly expressed genes, only protein-coding
genes with a mean log10 normalized expression value of − 1 or higher were
included. The Pearson’s (R) and Spearman’s correlation coefficients are
shown. (PDF 417 kb)
Additional file 10: Summary of enriched gene annotations for the set
of genes upregulated in the presence of Nutridoma. This Excel file contains
two sheets. The first contains a set of genes determined to be upregulated
in differentiation with Nutridoma relative to differentiation with DMSO
alone. This gene set was selected based on a mean log10 normalized
expression value of at least − 1 across our differentiation samples, and a
minimum 3-fold upregulation in each Nutridoma differentiation sample
compared to its corresponding DMSO differentiation sample (for both PLB-
985 and HL-60 cells). The table contains NCBI GeneIDs, Ensembl GeneIDs,
gene names, and the mean log10 normalized expression values in
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Nutridoma and DMSO differentiation samples. Sheet 2 contains a summary
of annotations enriched in for this set of upregulated genes. Annotation
enrichment was calculated using the DAVID online gene annotation analysis
tool [41]. (XLSX 34 kb)
Additional file 11: SNP analysis confirms that PLB-985 is genetically
identical to HL-60. Variant calling for genotyping was performed using
the GATK pipeline and the GATK best practices guidelines for each sample
from our RNA-Seq raw data and from the primary human neutrophil RNA-
Seq data. The heatmap indicates the fraction of loci with identical genotypes
for each pair of samples (see Methods for more details). (PDF 377 kb)
Additional file 12: Table of cell line and primary neutrophil gene expression
data. This comma separated value file contains the final averaged log10
normalized gene expression values for undifferentiated and differentiated
cell lines, as well as primary human and mouse neutrophils. This file
contains all of the data included in our online searchable neutrophil
gene expression database. (CSV 2970 kb)
Abbreviations
ATRA: All-trans retinoic acid; CA: Caffeic acid; CD11b: Integrin Alpha M,
ITGAM; dbcAMP: Dibutyryl cyclic adenosine monophosphate; DMF: N,N-
Dimethyl formamide; DMSO: Dimethyl sulfoxide; FACS: Fluorescence-
activated cell sorting; FBS: Fetal bovine serum; FLPEP: N-formyl-norleucyl-
leucyl-phenylalanyl-norleucyl-tyrosyl-lysine-fluorescein; fMLF: N-formyl-
methionyl-leucyl phenylalanine; FPR1: Formyl Peptide Receptor 1;
GATK: Genome Analysis Toolkit; G-CSF: Granulocyte colony-stimulating
factor; GEF: Guanine nucleotide exchange factor; MFI: Mean fluorescence
intensity; NBT: Nitro Blue tetrazolium; NCBI: National Center for Biotechnology
Information; P/S: Streptomycin and penicillin; PBS: Phosphate-buffered saline;
PMA: Phorbol 12-myristate 13-acetate; RNA-seq: RNA sequencing; SNPs: Single-
nucleotide polymorphisms
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